Invivyd, Inc. IVVD
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-08-06
Invivyd, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 7,542,061 | $6.6M | 2.67% |
| BlackRock Finance, Inc. | 4,473,808 | $4.9M | 1.59% |
| CITADEL ADVISORS LLC | 3,766,541 | $3.3M | 1.34% |
| TWO SIGMA INVESTMENTS, LP | 2,333,474 | $2.0M | 0.83% |
| MILLENNIUM MANAGEMENT LLC | 1,205,599 | $1.1M | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 995,334 | $868,329 | 0.35% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.